These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15816206)

  • 1. Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy.
    Moore GW; Rangarajan S; Holland LJ; Henley A; Savidge GF
    Br J Biomed Sci; 2005; 62(1):15-8; quiz 47. PubMed ID: 15816206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants.
    Della Valle P; Crippa L; Safa O; Tomassini L; Pattarini E; Vigano-D'Angelo S; Grazia Sabbadini M; D'Angelo A
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():10-4. PubMed ID: 8952752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of oral anticoagulation in patients with the antiphospholipid syndrome--influence of the lupus anticoagulant on International Normalized Ratio. Groupe Méthodologie en Hémostase du Groupe d'Etudes sur l'Hémostases et la Thrombose.
    Robert A; Le Querrec A; Delahousse B; Caron C; Houbouyan L; Boutière B; Horellou MH; Reber G; Sié P
    Thromb Haemost; 1998 Jul; 80(1):99-103. PubMed ID: 9684793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins.
    Tripodi A; Chantarangkul V; Clerici M; Negri B; Galli M; Mannucci PM
    Br J Haematol; 2001 Dec; 115(3):672-8. PubMed ID: 11736953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
    Thom J; Ivey L; Gilmore G; Eikelboom JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):353-7. PubMed ID: 15166923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
    Berkovsky A; Sergeeva EV; Suvorov AV; Uljavova IS; Kachalova ND; Klimovich LG; Samsonova NN; Kozlov AA
    Clin Chem Lab Med; 2006; 44(10):1214-7. PubMed ID: 17032133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.
    Adcock DM; Gosselin RC
    Int J Lab Hematol; 2017 May; 39 Suppl 1():37-40. PubMed ID: 28447415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.
    Harder S; Graff J; Klinkhardt U; von Hentig N; Walenga JM; Watanabe H; Osakabe M; Breddin HK
    Thromb Haemost; 2004 Jun; 91(6):1137-45. PubMed ID: 15175800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT).
    Gosselin RC
    Methods Mol Biol; 2023; 2663():289-295. PubMed ID: 37204718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a recombinant thromboplastin with Thrombotest for oral anticoagulant control.
    Baele G; Fiers T; Leroux-Roels G
    Haemostasis; 1996; 26(1):11-5. PubMed ID: 8698273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy.
    Jackson CM; Esnouf MP; Lindahl TL
    Pathophysiol Haemost Thromb; 2003; 33(1):43-51. PubMed ID: 12853712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 17. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method.
    Khoschnewis S; Hannes FM; Tschopp M; Wuillemin WA
    Thromb Res; 2004; 113(5):327-32. PubMed ID: 15183045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of STA-NeoPTimal, an extraction thromboplastin reagent with ISI close to 1.
    Carta M; Bonente F; Teresa Comberlato M; Pellizzari T; Marotto E; Marzari E; Giavarina D
    Int J Lab Hematol; 2021 Apr; 43(2):311-317. PubMed ID: 33070473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
    Crowl A; Schullo-Feulner A; Moon JY
    Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy.
    van Geest-Daalderop JH; Mulder AB; Boonman-de Winter LJ; Hoekstra MM; van den Besselaar AM
    Clin Chem; 2005 Mar; 51(3):561-8. PubMed ID: 15650035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.